[1-(6-Cyclopropylamino-pyrimidin-4-yl)-piperidin-4-yl]-methanol, 95.0%, 100mg

(S)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-(3-BROMOPHENYL)BUTANOIC ACID, 95%, 1g

4-Bromo-1,2-dimethoxybenzene, 97.0%, 25g

GC capillary column ROTI®Cap-1701, 25 m, 0.32 mm, 0.35 µm, 1 Piece(s)

(S)-3-AMINO-3-(3-FLUOROPHENYL)PROPANOIC ACID HCL, 97.0%, 10g

METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-2-(OXETAN-3-YL)ACETATE, 95.0%, 25g

N,N-Dimethyl-2-cyanoacetamide, 95.0%, 10g

(R)-1-Benzyl-N,N-dimethylpyrrolidin-3-amine, 95.0%, 250mg

1-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)INDOLIN-2-ONE, 95.0%, 100mg

Test tube stands ROTILABO® Stainless steel compartment size 18 x 18 mm, No. of slots, 24, 2 x 12, 1 Piece

5-amino-3,4-dihydropyrimidin-4-one, 95%, 1g

1-[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]-1H-pyrrole-2-carbaldehyde, 250mg

4,4',4''-Tris[9,9-dimethylfluoren-2-yl(phenyl)amino]triphenylamine, 98%, 200mg